A Parsimonious Ultrasound Radiomics and Ki-67 Model for Estimating MammaPrint Risk Categorization in HR+/HER2− Early Breast Cancer
Current Oncology · 04.08.2026 · 33 (8) · 464
DOI: 10.3390/curroncol33080464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 04.08.2026. Verfasst von Yuanjing Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuy…. Hauptthemen laut MEDLINE: Breast Neoplasms, Ki-67 Antigen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, National Health Commission.
Abstract (Originalsprache)
The 70-gene signature (70-GS; MammaPrint) assay is useful for prognosis assessment in HR+/HER2− early breast cancer, but limited accessibility motivates development of noninvasive alternatives. We retrospectively enrolled 219 women with preoperative grayscale ultrasound and 70-GS results, including a development cohort (n = 125), an internal validation cohort (n = 53), and a temporally independent validation cohort (n = 41). Radiomic features were extracted from manually delineated ROIs using PyRadiomics, and a radiomics score was derived after LASSO selection. Candidate radiomics-only, clinicopathologic-only, and full clinicoradiomic models were explored. To reduce overfitting, we selected a parsimonious model combining the radiomics score and Ki67 as the primary model. The simplified model achieved AUCs of 0.878, 0.816, and 0.831 in the development, internal validation, and temporally independent validation cohorts, respectively. In 1000 bootstrap resamples, the optimism-corrected AUC was 0.872 and the corrected calibration slope was 0.953. Adding the radiomics score to a Ki67-only model significantly improved model fit (likelihood-ratio chi-square = 17.14, df = 1, p < 0.001). An ultrasound radiomics and Ki67 model may provide a noninvasive reference for estimating MammaPrint risk categorization, but it should be considered only as a supportive adjunct and not as a replacement for genomic testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
- Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
ORCID-Profile: Qingli Zhu
Förderung
- Chinese Academy of Medical Sciences & Peking Union Medical College
- Peking Union Medical College Hospital
- National Health Commission
Zitieren
APA
Gao, Y., Luo, Y., Niu, Z., Zhou, M., Xiao, M., Chen, T., Lu, J., Jiang, Y., Pan, B., & Zhu, Q. (2026). A Parsimonious Ultrasound Radiomics and Ki-67 Model for Estimating MammaPrint Risk Categorization in HR+/HER2− Early Breast Cancer. Current Oncology, 33(8), 464. https://doi.org/10.3390/curroncol33080464
Vancouver
Gao Y, Luo Y, Niu Z, Zhou M, Xiao M, Chen T, et al. A Parsimonious Ultrasound Radiomics and Ki-67 Model for Estimating MammaPrint Risk Categorization in HR+/HER2− Early Breast Cancer. Current Oncology. 2026;33(8):464. doi:10.3390/curroncol33080464
BibTeX
@article{Gao2026,
author = {Gao, Yuanjing and Luo, Yanwen and Niu, Zihan and Zhou, Mengyuan and Xiao, Mengsu and Chen, Tianjiao and Lu, Jia and Jiang, Yuxin and Pan, Bo and Zhu, Qingli},
title = {A Parsimonious Ultrasound Radiomics and Ki-67 Model for Estimating MammaPrint Risk Categorization in HR+/HER2− Early Breast Cancer},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {8},
pages = {464},
doi = {10.3390/curroncol33080464}
}
EUVIMED